Nuclear projects demand precision, trust, and proven expertise. Element supports utilities, manufacturers, and engineering teams with testing and qualification services that keep systems safe, compliant, and ready to perform—delivering data-driven insight to meet regulations and extend asset life.

Learn More

Research & Applications

IAEA COVID-19 project draws more than $28 million in funding

May 15, 2020, 11:24AMNuclear News

A health worker at the IAEA Seibersdorf Laboratories in Austria packs a COVID-19 support equipment package, which includes personal protective equipment, PCR machines, reagents, and laboratory consumables. Photo: D. Calma/IAEA

An initiative by the International Atomic Energy Agency to help nearly 120 countries contain the COVID-19 pandemic has received a financial boost from member states and Takeda Pharmaceutical Company Limited.

The IAEA announced on May 13 that Takeda, a biopharmaceutical company based in Tokyo, donated 500 million yen (about US$4.7 million). Two days earlier, the IAEA announced that pledges from more than 10 member nations totaled €22 million (about US$23.8 million).

To continue reading, log in or create a free account!

Related Articles

Kenya, Rwanda eye nuclear reactors

April 8, 2026, 1:01PMNuclear News

Kenya and Rwanda are continuing to make progress toward deployment of their first nuclear reactors sometime in the near future, according to recent developments coming out of the African...